Suppr超能文献

腹膜透析患者转为血液透析的结局:一项竞争风险分析。

Outcomes of peritoneal dialysis patients and switching to hemodialysis: a competing risks analysis.

作者信息

Pajek Jernej, Hutchison Alastair J, Bhutani Shiv, Brenchley Paul E C, Hurst Helen, Perme Maja Pohar, Summers Angela M, Vardhan Anand

机构信息

Department of Nephrology, University Medical Center Ljubljana, Slovenia; Manchester Royal Infirmary Renal Unit, Manchester, UK; Manchester Institute of Nephrology and Transplantation, Manchester Royal Infirmary, Manchester, UK; and Institute for Biostatistics and Medical Informatics, Faculty of Medicine, Ljubljana, Slovenia.

出版信息

Perit Dial Int. 2014 May;34(3):289-98. doi: 10.3747/pdi.2012.00248. Epub 2014 Feb 4.

Abstract

BACKGROUND

We performed a review of a large incident peritoneal dialysis cohort to establish the impact of current practice and that of switching to hemodialysis.

METHODS

Patients starting peritoneal dialysis between 2004 and 2010 were included and clinical data at start of dialysis recorded. Competing risk analysis and Cox proportional hazards model with time-varying covariate (technique failure) were used.

RESULTS

Of 286 patients (median age 57 years) followed for a median of 24.2 months, 76 were transplanted and 102 died. Outcome probabilities at 3 and 5 years respectively were 0.69 and 0.53 for patient survival (or transplantation) and 0.33 and 0.42 for technique failure. Peritonitis caused technique failure in 42%, but ultrafiltration failure accounted only for 6.3%. Davies comorbidity grade, creatinine and obesity (but not residual renal function or age) predicted technique failure. Due to peritonitis deaths, technique failure was an independent predictor of death hazard. When successful switch to hemodialysis (surviving more than 60 days after technique failure) and its timing were analyzed, no adverse impact on survival in adjusted analysis was found. However, hemodialysis via central venous line was associated with an elevated death hazard as compared to staying on peritoneal dialysis, or hemodialysis through a fistula (adjusted analysis hazard ratio 1.97 (1.02 - 3.80)).

CONCLUSIONS

Once the patients survive the first 60 days after technique failure, the switch to hemodialysis does not adversely affect patient outcomes. The nature of vascular access has a significant impact on outcome after peritoneal dialysis failure.

摘要

背景

我们对一个大型腹膜透析队列进行了回顾,以确定当前治疗方式及转为血液透析的影响。

方法

纳入2004年至2010年间开始腹膜透析的患者,并记录透析开始时的临床数据。采用竞争风险分析和带有时间变化协变量(技术失败)的Cox比例风险模型。

结果

在随访的286例患者(中位年龄57岁)中,中位随访时间为24.2个月,76例接受了移植,102例死亡。患者生存(或移植)的3年和5年结局概率分别为0.69和0.53,技术失败的概率分别为0.33和0.42。腹膜炎导致42%的技术失败,但超滤失败仅占6.3%。戴维斯合并症分级、肌酐和肥胖(而非残余肾功能或年龄)可预测技术失败。由于腹膜炎死亡,技术失败是死亡风险的独立预测因素。在分析成功转为血液透析(技术失败后存活超过60天)及其时机时,校正分析未发现对生存有不利影响。然而,与继续进行腹膜透析或通过动静脉内瘘进行血液透析相比,通过中心静脉置管进行血液透析与死亡风险升高相关(校正分析风险比1.97(1.02 - 3.80))。

结论

一旦患者在技术失败后存活60天以上,转为血液透析不会对患者结局产生不利影响。血管通路的性质对腹膜透析失败后的结局有显著影响。

相似文献

7
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
10
Peritoneal Dialysis Technique Survival: A Cohort Study.腹膜透析技术生存率:一项队列研究。
Am J Kidney Dis. 2024 Sep;84(3):298-305.e1. doi: 10.1053/j.ajkd.2024.03.012. Epub 2024 Apr 17.

引用本文的文献

2
Hyperspectral evaluation of vasculature in induced peritonitis mouse models.诱导性腹膜炎小鼠模型中脉管系统的高光谱评估
Biomed Opt Express. 2022 May 18;13(6):3461-3475. doi: 10.1364/BOE.460288. eCollection 2022 Jun 1.
4
Optimization of Dialysis Modality Transitions for Improved Patient Care.优化透析方式转换以改善患者护理
Can J Kidney Health Dis. 2019 Oct 16;6:2054358119882664. doi: 10.1177/2054358119882664. eCollection 2019.

本文引用的文献

1
Global trends in rates of peritoneal dialysis.全球腹膜透析率趋势。
J Am Soc Nephrol. 2012 Mar;23(3):533-44. doi: 10.1681/ASN.2011060607. Epub 2012 Feb 2.
7
Outcome of hemodialysis patients who had failed peritoneal dialysis.腹膜透析失败患者的血液透析结果。
Nephron Clin Pract. 2010;116(4):c300-6. doi: 10.1159/000318793. Epub 2010 Jul 16.
8
Slouching towards Bethlehem: the beast of biocompatibility.向伯利恒踉跄前行:生物相容性之兽。
Nephrol Dial Transplant. 2010 Jul;25(7):2050-1. doi: 10.1093/ndt/gfq213. Epub 2010 Apr 15.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验